Healthcare provider profile · identity verified

Danielle Wurtz

Family Practice · MARYSVILLE, KS · NPI 1639515026

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	197	27
Atorvastatin Calcium	Atorvastatin Calcium	157	27
Gabapentin	Gabapentin	132	19
Citalopram Hbr	Citalopram Hydrobromide	109	suppressed
Omeprazole	Omeprazole	106	17
Potassium Chloride	Potassium Chloride	89	16
Warfarin Sodium	Warfarin Sodium	86	suppressed
Montelukast Sodium	Montelukast Sodium	81	12
Simvastatin	Simvastatin	80	12
Albuterol Sulfate Hfa	Albuterol Sulfate	78	13
Amlodipine Besylate	Amlodipine Besylate	74	13
Metoprolol Succinate	Metoprolol Succinate	74	13
Lisinopril	Lisinopril	72	15
Hydrochlorothiazide	Hydrochlorothiazide	70	15
Tamsulosin Hcl	Tamsulosin Hcl	65	suppressed
Metformin Hcl Er	Metformin Hcl	64	12
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	59	16
Pantoprazole Sodium	Pantoprazole Sodium	57	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	54	suppressed
Sertraline Hcl	Sertraline Hcl	53	suppressed
Furosemide	Furosemide	51	suppressed
Famotidine	Famotidine	49	suppressed
Losartan Potassium	Losartan Potassium	48	suppressed
Donepezil Hcl	Donepezil Hcl	46	suppressed
Myrbetriq	Mirabegron	46	suppressed
Primidone	Primidone	45	suppressed
Trazodone Hcl	Trazodone Hcl	42	suppressed
Clonazepam	Clonazepam	40	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	38	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	37	suppressed
Eliquis	Apixaban	37	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	37	suppressed
Duloxetine Hcl	Duloxetine Hcl	35	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	35	suppressed
Allopurinol	Allopurinol	32	suppressed
Prednisone	Prednisone	32	14
Fentanyl	Fentanyl	31	suppressed
Gemtesa	Vibegron	30	suppressed
Levetiracetam	Levetiracetam	30	suppressed
Propranolol Hcl	Propranolol Hcl	30	suppressed
Spironolactone	Spironolactone	29	suppressed
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	28	suppressed
Oxycodone Hcl	Oxycodone Hcl	28	suppressed
Buspirone Hcl	Buspirone Hcl	27	suppressed
Latanoprost	Latanoprost	27	suppressed
Temazepam	Temazepam	27	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	26	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	26	suppressed
Solifenacin Succinate	Solifenacin Succinate	26	suppressed
Mirtazapine	Mirtazapine	25	suppressed
Vilazodone Hcl	Vilazodone Hcl	25	suppressed
Aripiprazole	Aripiprazole	24	suppressed
Lorazepam	Lorazepam	24	suppressed
Torsemide	Torsemide	24	suppressed
Farxiga	Dapagliflozin Propanediol	23	suppressed
Quetiapine Fumarate Er	Quetiapine Fumarate	23	suppressed
Vyvanse	Lisdexamfetamine Dimesylate	23	suppressed
Alprazolam	Alprazolam	22	suppressed
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	20	suppressed
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	20	suppressed
Metformin Hcl	Metformin Hcl	20	suppressed
Pregabalin	Pregabalin	19	suppressed
Hydrocortisone	Hydrocortisone	18	suppressed
Tizanidine Hcl	Tizanidine Hcl	18	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	18	suppressed
Celecoxib	Celecoxib	17	suppressed
Colestipol Hcl	Colestipol Hcl	17	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	17	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	16	suppressed
Linzess	Linaclotide	16	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	16	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	16	suppressed
Tramadol Hcl	Tramadol Hcl	16	suppressed
Trulicity	Dulaglutide	16	suppressed
Alendronate Sodium	Alendronate Sodium	15	suppressed
Atenolol	Atenolol	15	suppressed
Azelastine Hcl	Azelastine Hcl	15	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	15	suppressed
Janumet Xr	Sitagliptin Phos/Metformin Hcl	15	suppressed
Olanzapine	Olanzapine	15	suppressed
Sucralfate	Sucralfate	15	suppressed
Xarelto	Rivaroxaban	15	suppressed
Bupropion Xl	Bupropion Hcl	14	suppressed
Incruse Ellipta	Umeclidinium Bromide	14	suppressed
Lamotrigine	Lamotrigine	14	suppressed
Ondansetron Odt	Ondansetron	14	suppressed
Pravastatin Sodium	Pravastatin Sodium	14	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	13	suppressed
Carbamazepine	Carbamazepine	13	suppressed
Carbidopa-Levodopa Er	Carbidopa/Levodopa	13	suppressed
Entacapone	Entacapone	13	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	13	suppressed
Estradiol	Estradiol	13	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	13	suppressed
Nystatin	Nystatin	13	suppressed
Ropinirole Hcl	Ropinirole Hcl	13	suppressed
Topiramate	Topiramate	13	suppressed
Ventolin Hfa	Albuterol Sulfate	13	suppressed
Aripiprazole Odt	Aripiprazole	12	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	12	suppressed
Digoxin	Digoxin	12	suppressed
Dorzolamide-Timolol	Dorzolamide Hcl/Timolol Maleat	12	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	12	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	12	suppressed
Fluvoxamine Maleate	Fluvoxamine Maleate	12	suppressed
Januvia	Sitagliptin Phosphate	12	suppressed
Memantine Hcl	Memantine Hcl	12	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	12	suppressed
Risperidone	Risperidone	12	suppressed
Valproic Acid	Valproic Acid	12	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	12	suppressed
Ezetimibe	Ezetimibe	11	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	11	suppressed
Metolazone	Metolazone	11	suppressed
Morphine Sulfate	Morphine Sulfate	11	suppressed
Synthroid	Levothyroxine Sodium	11	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	11	suppressed
Xtampza Er	Oxycodone Myristate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error